[Perhaps an explanation for the therapeutic escape of prostate cancer treated with antiandrogens].
Jeanteur
P
P
D000726:Androgen Antagonists / Q000378:metabolism / Q000627:therapeutic use*; D013196:Dihydrotestosterone / Q000378:metabolism / Q000627:therapeutic use; D019008:Drug Resistance, Neoplasm / Q000235:genetics; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000235:genetics*; D017354:Point Mutation / Q000235:genetics*; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000235:genetics*; D011944:Receptors, Androgen / Q000235:genetics* / Q000378:metabolism; D014407:Tumor Cells, Cultured / Q000187:drug effects; D014960:X Chromosome / Q000235:genetics
D000726:Androgen Antagonists; D011944:Receptors, Androgen; D013196:Dihydrotestosterone; D006854:Hydrocortisone